Equality in research drives innovation
Statement from Federal Research Minister Bär:
“Equality is essential for Germany’s capacity for innovation and long-term competitiveness. It is a decisive driver of progress. If we want to address the major challenges and megatrends of our time, be it digitalization, space research, medicine of the future, or key technologies, we cannot afford to leave half of the brightest minds out of driving Germany’s future forward. This is why the Federal Ministry of Education and Research, together with the states, is supporting equality at universities with a 2030 female professors program and the visibility of female researchers with the “Focus on Innovative Women” funding guidelines. In order to further strengthen social awareness of gender issues in research, we are currently designing a federal scientific award for gender research, which is to be announced later this year.”
Statement from Professor Maike Sander, Scientific Director and Chair of the Executive Board of the Max Delbrück Center:
“The discoveries made at the Max Delbrück Center lay the foundation for the medicine of the future. To get there, we need talented individuals who are enthusiastic about innovation and eager to contribute their ideas – regardless of gender or background. A total of 60 percent of our researchers are women. We have also been successful in recruiting early-career female group leaders. However, we still have some catching up to do when it comes to permanent professorships. This is why we specifically promote female scientists, for example through mentoring programs. We also approach exceptional candidates worldwide. More than half of our group leaders have been recruited internationally. We want to create an inspiring environment for all of them. We need a scientific culture in which careers are defined not by traditional role expectations, but by curiosity, talent, and courage. There is still much to be done.”
Further information
Contact
Tabea Rauscher
Communications und Marketing
Max Delbrück Center
030 — 9406 2140
presse@mdc-berlin.de
- Max Delbrück Center
The Max Delbrück Center for Molecular Medicine in the Helmholtz Association lays the foundation for the medicine of tomorrow through our discoveries of today. At locations in Berlin-Buch, Berlin-Mitte, Heidelberg, and Mannheim, interdisciplinary teams investigate the complexity of disease at the systems level – from molecules and cells to organs and entire organisms. Together with academic, clinical, and industry partners, and as part of global networks, we turn biological insights into innovations for early detection, personalized therapies, and disease prevention. Founded in 1992, the Max Delbrück Center is home to a vibrant, international research community of around 1,800 people from over 70 countries. We are 90 percent funded by the German federal government and 10 percent by the state of Berlin.